Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • @[email protected]
    link
    fedilink
    830 days ago

    In 30 years they’re going to squirt genetically modified copies of you into corporate artificial uteruses and that’s how they will meet their worker needs.